Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

709
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
709
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

824
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
824
Freezing Point Depression and Boiling Point Elevation03:12

Freezing Point Depression and Boiling Point Elevation

41.3K
Boiling Point Elevation
The boiling point of a liquid is the temperature at which its vapor pressure is equal to ambient atmospheric pressure. Since the vapor pressure of a solution is lowered due to the presence of nonvolatile solutes, it stands to reason that the solution’s boiling point will subsequently be increased. Vapor pressure increases with temperature, and so a solution will require a higher temperature than will pure solvent to achieve any given vapor pressure, including one...
41.3K
Long-term Depression01:05

Long-term Depression

33.4K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.4K
Complement System01:27

Complement System

11.0K
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
11.0K
Complementation Tests00:49

Complementation Tests

6.3K
A complementation test is a simple cross to identify whether the two mutations are located on the same gene or different genes. It was first performed by Edward Lewis in the 1940s while working on fruit flies. He developed the test to identify the location and arrangement of different mutations on chromosomes.
Organisms heterozygous for different mutations are crossed pairwise in all combinations. If present on different genes, the mutations can complement each other by providing the missing...
6.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Honokiol attenuates neuroinflammation and enhances remyelination in mouse models of multiple sclerosis through PPARγ-mediated ERK/AKT signalling.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2026
Same author

Widespread white matter microstructural abnormalities in treatment‑naïve patients with first‑episode schizophrenia revealed by fixel-based analysis.

Translational psychiatry·2026
Same author

Peripheral transcriptomic aging acceleration in major depressive disorder: the mediating role of insular cortex alterations.

Psychological medicine·2026
Same author

Altered perivascular water diffusivity links childhood trauma and major depressive disorder: A multimodal integration of cognition, neuroimaging, and transcriptomics.

Journal of affective disorders·2026
Same author

Corrigendum to "Generation of two induced pluripotent stem cell (iPSC) lines (HZSMHCI001-A and HZSMHCI004-A) from a mother-child dyad with major depressive disorder and bipolar disorder" [Stem Cell Res. 91 (2026) 103920].

Stem cell research·2026
Same author

Age-Dependent Corpus Callosum Thickness Abnormalities and Clinical Implications in Treatment-Naïve First-Episode Schizophrenia.

Alpha psychiatry·2026

Related Experiment Video

Updated: Feb 16, 2026

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

1.6K

Plasma complement component 4 increases in patients with major depressive disorder.

Jinxue Wei1, Ye Liu1, Liansheng Zhao1

  • 1Psychiatric Laboratory and Mental Health Center, Huaxi Brain Research Center, West China Hospital of Sichuan University, Chengdu, China.

Neuropsychiatric Disease and Treatment
|January 6, 2018
PubMed
Summary

Major depressive disorder (MDD) is linked to elevated complement component 4 (C4) levels. Antidepressant treatment significantly reduced C4, suggesting its role in MDD pathophysiology and potential as a biomarker.

Keywords:
C4depressioninflammation

More Related Videos

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

14.7K
Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
05:19

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

3.5K

Related Experiment Videos

Last Updated: Feb 16, 2026

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

1.6K
MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

14.7K
Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
05:19

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

3.5K

Area of Science:

  • Neuroscience
  • Immunology
  • Psychiatry

Background:

  • Major depressive disorder (MDD) is associated with inflammation, but findings on inflammatory factors are inconsistent.
  • Complement components, like complement component 4 (C4), may influence MDD pathophysiology through inflammatory pathways.
  • C4's role in neural synapse elimination and its association with schizophrenia suggest potential involvement in MDD.

Purpose of the Study:

  • To investigate plasma concentrations of C4 and key inflammatory factors in patients with MDD compared to healthy controls.
  • To explore the correlation between C4, inflammatory factors, and depressive/anxiety symptoms.
  • To assess the effect of antidepressant medication on plasma C4 levels in MDD patients.

Main Methods:

  • Plasma C4 and inflammatory factor levels (IL-1β, IL-6, IL-8, IL-10, IFN-α, IFN-γ, TNF-α) were measured in 53 MDD patients and 60 healthy controls.
  • Plasma samples from 17 MDD patients post-antidepressant treatment were also analyzed.
  • Statistical analyses were performed to compare groups and assess correlations.

Main Results:

  • Peripheral C4 levels were significantly higher in MDD patients than in healthy controls.
  • No significant correlations were found between inflammatory factors or C4 levels and the severity of depressive or anxiety symptoms.
  • Antidepressant medication led to a significant reduction in plasma C4 levels in MDD patients.

Conclusions:

  • Elevated C4 in MDD supports its potential role in the disorder's pathophysiology.
  • C4 may serve as a candidate biomarker for MDD research.
  • Further investigation into C4's specific mechanisms in MDD is warranted.